ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,644Medicare Part D Prescriptions Filled, Including Refills
$718K Total Retail Price of All Prescriptions
451 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 578 489 S3
SIMVASTATIN 489 421
POTASSIUM CHLORIDE 388 299
LEVOTHYROXINE SODIUM 367 272
OMEPRAZOLE 351 275
FUROSEMIDE 332 213
AMLODIPINE BESYLATE 270 200
LISINOPRIL 270 189
ZOLPIDEM TARTRATE 238 175
CITALOPRAM HBR 203 172
GABAPENTIN 190 113
METOPROLOL TARTRATE 183 143
WARFARIN SODIUM 171 146
ALENDRONATE SODIUM 156 140
GLIMEPIRIDE 138 65
METFORMIN HCL 136 98
TRAMADOL HCL 122 76
CRESTOR 122 100
BUMETANIDE 121 69
HYDROCHLOROTHIAZIDE 120 108
ATORVASTATIN CALCIUM 110 52
PROAIR HFA 109 56
PAROXETINE HCL 107 72
FENOFIBRATE 107 67
CYCLOBENZAPRINE HCL 106 41 R
CYMBALTA 99 39
MELOXICAM 98 58
PRAVASTATIN SODIUM 95 79
DIOVAN 94 60
METOPROLOL SUCCINATE 83 52
TAMSULOSIN HCL 82 80
LANTUS SOLOSTAR 82 48
LOSARTAN POTASSIUM 80 56
ALLOPURINOL 78 65
FAMOTIDINE 77 64
ATENOLOL 76 74
NOVOLOG FLEXPEN 70 43
CLONIDINE HCL 69 51
LYRICA 67 38
CLOPIDOGREL 65 65
BENAZEPRIL HCL 65 61
SERTRALINE HCL 65 45
DONEPEZIL HCL 63 62
ZETIA 63 38
LOSARTAN-HYDROCHLOROTHIAZIDE 61 42
INSULIN SYRINGE 61 36
NEXIUM 59 17
ISOSORBIDE MONONITRATE ER 59 38
LANTUS 58 27
PEN NEEDLE 57 22
ACTOS 57 36
SPIRONOLACTONE 57 35
PRAMIPEXOLE DIHYDROCHLORIDE 57 55
GLYBURIDE 56 53 R
MIRTAZAPINE 54 31
COMBIVENT 53 23
OXYBUTYNIN CHLORIDE 53 37
PREDNISONE 51 17
ADVAIR DISKUS 50 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.